A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany
暂无分享,去创建一个
O. Cornely | Florian Jakobs | Sebastian M Wingen-Heimann | Julia Jeck | A. Kron | F. Kron | F. Jakobs